bmy 42393 has been researched along with selexipag in 1 studies
| Studies (bmy 42393) | Trials (bmy 42393) | Recent Studies (post-2010) (bmy 42393) | Studies (selexipag) | Trials (selexipag) | Recent Studies (post-2010) (selexipag) |
|---|---|---|---|---|---|
| 21 | 0 | 1 | 148 | 32 | 134 |
| Protein | Taxonomy | bmy 42393 (IC50) | selexipag (IC50) |
|---|---|---|---|
| Prostacyclin receptor | Homo sapiens (human) | 0.062 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaki, T; Hamamoto, T; Kuwabara, K; Kuwano, K; Sugiyama, Y | 1 |
1 other study(ies) available for bmy 42393 and selexipag
| Article | Year |
|---|---|
Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists.
Topics: Humans; Pyrazines; Receptors, Epoprostenol; Structure-Activity Relationship | 2007 |